Nitroglycerin-induced aortic relaxation mediated by calcium-activated potassium channel is markedly diminished in hypertensive rats.

[1]  Yongxiang Wang,et al.  Vascular pharmacology of methylene blue in vitro and in vivo: a comparison with NG‐nitro‐l‐arginine and diphenyleneiodonium , 1995, British journal of pharmacology.

[2]  N. Rusch,et al.  Remission of high blood pressure reverses arterial potassium channel alterations. , 1994, Hypertension.

[3]  R. Cohen,et al.  Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle , 1994, Nature.

[4]  J. Catravas,et al.  Smooth muscle cell responsiveness to nitrovasodilators in hypertensive and normotensive rats. , 1994, Hypertension.

[5]  W. Mathews,et al.  Role of calcium-activated K+ channels in vasodilation induced by nitroglycerine, acetylcholine and nitric oxide. , 1993, The Journal of pharmacology and experimental therapeutics.

[6]  T. Kolias,et al.  Potassium channel antagonists and vascular reactivity in stroke-prone spontaneously hypertensive rats. , 1993, American journal of hypertension.

[7]  M. Hamaguchi,et al.  Involvement of charybdotoxin-sensitive K+ channel in the relaxation of bovine tracheal smooth muscle by glyceryl trinitrate and sodium nitroprusside. , 1992, The Journal of pharmacology and experimental therapeutics.

[8]  N. Miyata,et al.  Impairment of Endothelium‐dependent Relaxation and Changes in Levels of cyclic GMP in Carotid Arteries from Stroke‐prone Spontaneously Hypertensive Rats , 1990, The Journal of pharmacy and pharmacology.

[9]  P. Karczewski,et al.  Studies of the effect of glyceryl trinitrate and cyclic GMP on calcium turnover in bovine mesenteric artery. , 1990, Pharmacology & toxicology.

[10]  R. Bentley,et al.  Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle. , 1989, The Journal of pharmacology and experimental therapeutics.

[11]  W. Halpern,et al.  Endothelium-dependent and endothelium-independent vasodilation in resistance arteries from hypertensive rats. , 1988, Hypertension.

[12]  G. A. Nickols,et al.  Endothelial regulation of cyclic GMP and vascular responses in hypertension. , 1988, The Journal of pharmacology and experimental therapeutics.

[13]  R. MacKinnon,et al.  Charybdotoxin block of single Ca2+-activated K+ channels. Effects of channel gating, voltage, and ionic strength , 1988, The Journal of general physiology.

[14]  R. MacKinnon,et al.  Mechanism of charybdotoxin block of the high-conductance, Ca2+- activated K+ channel , 1988, The Journal of general physiology.

[15]  T. Satake,et al.  Role of cyclic GMP of canine vascular smooth muscle in relaxation by organic nitrates. , 1986, Japanese circulation journal.

[16]  T. Lüscher,et al.  Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. , 1986, Hypertension.

[17]  T. Sasaguri,et al.  Nitroglycerine‐ and isoprenaline‐induced vasodilatation: assessment from the actions of cyclic nucleotides , 1985, British journal of pharmacology.

[18]  C. Su,et al.  Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. , 1983, Hypertension.

[19]  J. Wikberg,et al.  Relationship between nitroglycerin, cyclic GMP and relaxation of vascular smooth muscle. , 1979, Life sciences.

[20]  Y. Nakaya,et al.  Effects of nitroglycerin on ATP-induced Ca(++)-mobilization, Ca(++)-activated K channels and contraction of cultured smooth muscle cells of porcine coronary artery. , 1991, The Journal of pharmacology and experimental therapeutics.

[21]  L. Ignarro,et al.  The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. , 1985, Annual review of pharmacology and toxicology.